Hint mode is switched on Switch off

Vera Therapeutics, ordinary share
VERA, US92337R1014

Add a stock to WL
Choose all Reset all
Vera Therapeutics, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Unlock data Watch full tour

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
Vera Therapeutics, Inc. operates as a clinical stage biotechnology company. The Company focuses on developing and commercializing transformative treatments for patients with serious immunological diseases. Vera Therapeutics serves customers worldwide.
  • Issuer
  • Full borrower / issuer name
    Vera Therapeutics, Inc.
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    VERA
  • Placement
    14.05.2021
  • Lock up period
    180
  • Number of papers
    4,350,000
  • Volume of raised funds
    47.85 mln USD
  • Placement share
    21.24%
  • Final placement price
    11 USD
  • Price change since placement date
    -100%
  • By capitalization
    225.27 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    VERA
  • Placement
    11.02.2022
  • Lock up period
    180
  • Number of papers
    4,993,067
  • Volume of raised funds
    74.9 mln USD
  • Placement share
    19.01%
  • Final placement price
    15 USD
  • Price change since placement date
    -100%
  • By capitalization
    394.06 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    VERA
  • Placement
    02.02.2023
  • Lock up period
    180
  • Number of papers
    41,893,164
  • Volume of raised funds
    100 mln USD
  • Placement share
    34.1%
  • Final placement price
    7 USD
  • Price change since placement date
    372.14%
  • By capitalization
    293.25 mln USD
Other placements of the issuer Hide

IFRS/US GAAP reports

2026
I q eng
2025
I q eng
IV q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
Show all Hide

Related Stock indices

Indicators

News

02/06/2026 Vera Therapeutics: Other Events
28/11/2025 Vera Therapeutics' Stock Sees Bullish Outlook from Analysts
25/11/2025 Vera Therapeutics: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers
06/11/2025 Vera Therapeutics: Other Events, Financial Statements And Exhibits
05/08/2025 Vera Therapeutics: Entry Into A Material Definitive Agreement, Termination Of A Material Definitive Agreement, Financial Statements And Exhibits
All organization news

Holders

Industry Leaders

Registration is required to get access.